Until about 20 years ago, systemic treatment options for moderate/severe psoriasis were limited and nonspecific. To get an idea of how much the field has changed, clinical guidelines on psoriasis ...

Dr. Charles D. Neblett, co-founder of the SNCC Freedom Singers and civil rights icon. Neblett is currently battling stage 4 prostate cancer while leading the national Black Prostate Check Challenge™ ...

Send comments and news tips to [email protected]. Cite this: Upadacitinib Outperforms Mycophenolate in Treating Systemic Sclerosis-Associated ILD - Medscape - June 13, 2025.

EQT is believed to be planning to next year sell its cancer-care business, Icon Group, and has been preparing to appoint an investment bank for a deal in the coming weeks.

A retrospective analysis of US medical records of people aged 65-95 years finds those with psoriasis on systemic therapies have a lower risk for dementia than those not on the treatment.

A new study identifies eight domains of active systemic #lupus erythematosus for defining meaningful treatment response in lupus clinical trials.

This week, the American College of Rheumatology (ACR) released updated guidelines for the treatment and management of systemic lupus erythematosus (SLE), the most common form of lupus.

Lung cancer chemotherapy (chemo), targeted therapies, and immunotherapy are called systemic therapies. Treatments are given by mouth, intravenous (IV) infusion, or injection (shot). They spread ...

Ray Dalio is sounding the alarm — not just about a potential recession, but about a deeper, systemic breakdown of the global economic and political order in an interview with CNBC on Sunday.

VIDEO: Gentle skin care, systemic treatment, light therapy and more in atopic dermatitisEditor’s note: This is an automatically generated transcript. Please notify [email protected] if there are ...

Janus kinase (JAK) inhibitors, including ruxolitinib cream and abrocitinib, demonstrate strong efficacy in atopic dermatitis (AD), offering viable alternatives to systemic therapies.

ADI-001 has been granted Fast Track Designation by the FDA for the treatment of relapsed/refractory class III or class IV lupus nephritis (LN), systemic lupus erythematosus (SLE) with extrarenal ...